1
|
Soares PI, Ferreira IM, Igreja RA, Novo CM
and Borges JP: Application of hyperthermia for cancer treatment:
recent patents review. Recent Pat Anticancer Drug Discov. 7:64–73.
2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wust P, Hildebrandt B, Sreenivasa G, Rau
B, Gellermann J, Riess H, Felix R and Schlag PM: Hyperthermia in
combined treatment of cancer. Lancet Oncol. 3:487–497. 2002.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Falk MH and Issels RD: Hyperthermia in
oncology. Int J Hyperthermia. 17:1–18. 2001. View Article : Google Scholar
|
4
|
Ross MI: Current status of hyperthermic
limb perfusion for in-transit melanoma. Int J Hyperthermia.
24:205–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pennacchioli E, Fiore M and Gronchi A:
Hyperthermia as an adjunctive treatment for soft-tissue sarcoma.
Expert Rev Anticancer Ther. 9:199–210. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Harmon BV, Takano YS, Winterford CM and
Gobé GC: The role of apoptosis in the response of cells and tumours
to mild hyperthermia. Int J Radiat Biol. 59:489–501. 1991.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Horsman MR: Tissue physiology and the
response to heat. Int J Hyperthermia. 22:197–203. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Diederich CJ: Thermal ablation and
high-temperature thermal therapy: overview of technology and
clinical implementation. Int J Hyperthermia. 21:745–753. 2005.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Roti Roti JL: Cellular responses to
hyperthermia (40–46 degrees C): cell killing and molecular events.
Int J Hyperthermia. 24:3–15. 2008.
|
10
|
den Brok MH, Sutmuller RP, van der Voort
R, Bennink EJ, Figdor CG, Ruers TJ and Adema GJ: In situ tumor
ablation creates an antigen source for the generation of antitumor
immunity. Cancer Res. 64:4024–4029. 2004.
|
11
|
Baronzio G, Gramaglia A and Fiorentini G:
Hyperthermia and immunity. A brief overview. In Vivo. 20:689–695.
2006.
|
12
|
Zerbini A, Pilli M, Penna A, Pelosi G,
Schianchi C, Molinari A, Schivazappa S, Zibera C, Fagnoni FF,
Ferrari C and Missale G: Radiofrequency thermal ablation of
hepatocellular carcinoma liver nodules can activate and enhance
tumor-specific T-cell responses. Cancer Res. 66:1139–1146. 2006.
View Article : Google Scholar
|
13
|
Mukhopadhaya A, Mendecki J, Dong X, Liu L,
Kalnicki S, Garg M, Alfieri A and Guha C: Localized hyperthermia
combined with intratumoral dendritic cells induces systemic
antitumor immunity. Cancer Res. 67:7798–7806. 2007. View Article : Google Scholar
|
14
|
Zhang HG, Mehta K, Cohen P and Guha C:
Hyperthermia on immune regulation: a temperature’s story. Cancer
Lett. 271:191–204. 2008.
|
15
|
Moroz P, Jones SK and Gray BN:
Magnetically mediated hyperthermia: current status and future
directions. Int J Hyperthermia. 18:267–284. 2002. View Article : Google Scholar : PubMed/NCBI
|
16
|
Rees JH: Diagnosis and treatment in
neuro-oncology: an oncological perspective. Br J Radiol.
84:S82–S89. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Fiorentini G, Giovanis P, Rossi S, Dentico
P, Paola R, Turrisi G and Bernardeschi P: A phase II clinical study
on relapsed malignant gliomas treated with electro-hyperthermia. In
Vivo. 20:721–724. 2006.PubMed/NCBI
|
18
|
Bidwell GL 3rd, Perkins E, Hughes J, Khan
M, James JR and Raucher D: Thermally targeted delivery of a c-Myc
inhibitory polypeptide inhibits tumor progression and extends
survival in a rat glioma model. PLoS One. 8:e551042013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang DC, Zhang Y, Chen HY, Li XL, Qin LJ,
Li YJ, Zhang HY and Wang S: Hyperthermia promotes apoptosis and
suppresses invasion in C6 rat glioma cells. Asian Pac J Cancer
Prev. 13:3239–3245. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Stojkovic R and Radacic M: Cell killing of
melanoma B16 in vivo by hyperthermia and cytotoxins. Int J
Hyperthermia. 18:62–71. 2002. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ito A, Fujioka M, Yoshida T, et al:
4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for
combination therapy of hyperthermia with chemotherapy against
malignant melanoma. Cancer Sci. 98:424–430. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Haen SP, Pereira PL, Salih HR, Rammensee
HG and Gouttefangeas C: More than just tumor destruction:
immunomodulation by thermal ablation of cancer. Clin Dev Immunol.
1602502011.
|
23
|
Xia QS, Liu X, Xu B, Zhao TD, Li HY, Chen
ZH, Xiang Q, Geng CY, Pan L, Hu RL, et al: Feasibility study of
high-temperature thermoseed inductive hyperthermia in melanoma
treatment. Oncol Rep. 25:953–962. 2011.PubMed/NCBI
|
24
|
Li DY, Tang YP, Zhao LY, Geng CY and Tang
JT: Antitumor effect and immune response induced by local
hyperthermia in B16 murine melanoma: Effect of thermal dose. Oncol
Lett. 4:711–718. 2012.PubMed/NCBI
|
25
|
Brown DC and Gatter KC: Ki67 protein: the
immaculate deception? Histopathology. 40:2–11. 2002. View Article : Google Scholar
|
26
|
Lopez F, Belloc F, Lacombe F, Dumain P,
Reiffers J, Bernard P and Boisseau MR: Modalities of synthesis of
Ki67 antigen during the stimulation of lymphocytes. Cytometry.
12:42–49. 1991. View Article : Google Scholar : PubMed/NCBI
|
27
|
Prayson RA: The utility of MIB-1/Ki-67
immunostaining in the evaluation of central nervous system
neoplasms. Adv Anat Pathol. 12:144–148. 2005. View Article : Google Scholar
|